Clinical trial
A Multicenter, Single-Arm, Interventional, Phase 4 Study to Evaluate the Efficacy and Safety of Prucalopride in Combination With PEG or Lactulose in Women With Chronic Constipation (CC)
NCT02228616 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Single-Arm, Interventional, Phase 4 Study to Evaluate the Efficacy and Safety of Prucalopride in Combination With PEG or Lactulose in Women With Chronic Constipation (CC)
- Lead sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 14, 2014
- Completion date
- September 28, 2016
- Enrollment
- 280 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.